<DOC>
	<DOCNO>NCT01221805</DOCNO>
	<brief_summary>The purpose study demonstrate ability STA速 Liatest速 D-Di combine clinical pretest probability ( PTP ) safely exclude pulmonary embolism ( PE ) Deep Venous Thrombosis ( DVT ) 3 month follow-up .</brief_summary>
	<brief_title>STA速-Liatest速D-Di-Exclusion Venous Thromboembolism</brief_title>
	<detailed_description>The study population select prospective , consecutive ambulatory outpatient suspect venous thromboembolism . These patient first evaluate use Wells score : - patient low moderate pretest probability consider D-dimer test , D-dimer positive consider imaging procedure , - patient high pretest probability consider imaging procedure . Patients `` low moderate '' pretest probability negative D-Dimer result follow 3 month evaluate potential development deep venous thrombosis and/or pulmonary embolism . These patient contact phone 3 month first visit .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<criteria>INCLUSION CRITERIA 1 . Patient &lt; 80 year old . 2 . Patient present least one symptom indicative proximal DVT PE : symptom proximal DVT : leg pain , tenderness ( discomfort palpation ) , leg swelling , /or edema , symptom PE : hemoptysis , lung relate chest pain , dyspnea . 3 . Patient provide write informed consent participate study ( verbal noopposition , allow local regulation ) 4 . Patient willing comply specify followup evaluation 3 month contact telephone EXCLUSION CRITERIA 1 . Patient present condition may associate increase Ddimer level , even absence VTE , : Fibrinolytic therapy within previous seven ( 7 ) day , Bone fracture surgery ( general anesthesia longer thirty ( 30 ) minute ) within previous one ( 1 ) month , Deep hematoma diagnose image technique within previous one ( 1 ) month , Disseminated malignancy active cancer ( active cancer define : cancer therapeutic palliative treatment either ongoing time enrolment stop less six ( 6 ) month enrolment ) , Sepsis , severe infection , pneumonia within previous 1 month , Known liver cirrhosis , Pregnancy postpartum within previous 1 month , Atherosclerotic vascular disease thrombosis within previous 1month ( e.g . myocardial infarction , stroke , coronary syndrome , peripheral artery disease stage III IV ) , Sickle cell disease , 2 . Patients present suspect thrombotic event relate catheter implantation 3 . Ongoing therapeutic anticoagulant ( curative preventive treatment ) start twenty four ( 24 ) hour Ddimer measure 4 . Previous anticoagulant therapy stop less three ( 3 ) month Ddimer measure 5 . Patients previous DVT/PE occur less three ( 3 ) month screen . 6 . Suspect thrombotic event location screen , include distal knee upper extremity DVT ( base standard care examination ) 7 . Patients know tissue plasminogen activator ( tPA ) deficiency 8 . Patient participate participate within one month enrollment another investigational study 9 . Major comorbid condition ( ) reason could limit patient 's ability participate study comply followup requirement , impact scientific integrity study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>deep venous thrombosis</keyword>
	<keyword>pulmonary embolism</keyword>
	<keyword>venous thromboembolism</keyword>
	<keyword>D-dimer</keyword>
	<keyword>Wells score</keyword>
	<keyword>Wells clinical pretest probability</keyword>
</DOC>